Thereafter, high FRMD3 expression was reported to be related to advanced clinicopathological features in rectal cancer patients [8], and FRMD3 was shown to be the target of Has-miR-3651, a novel predictor for breast cancer recurrence [9]. This evidence concerns the gene FRMD3 and rectal cancer.